ProAR-Faculdade de Medicina da Universidade Federal da Bahia, Salvador, Brazil; Social Change, Asthma and Allergy in Latin America (SCAALA) Study Group, Salvador, Quito, and London.
Social Change, Asthma and Allergy in Latin America (SCAALA) Study Group, Salvador, Quito, and London; Institute of Infection and Immunity, St George's University of London, London, United Kingdom; Facultad de Ciencias Medicas, de la Salud y la Vida, Universidad Internacional del Ecuador, Quito, Ecuador.
J Allergy Clin Immunol. 2017 Nov;140(5):1217-1228. doi: 10.1016/j.jaci.2017.09.005.
Allergic diseases are on the increase globally in parallel with a decrease in parasitic infection. The inverse association between parasitic infections and allergy at an ecological level suggests a causal association. Studies in human subjects have generated a large knowledge base on the complexity of the interrelationship between parasitic infection and allergy. There is evidence for causal links, but the data from animal models are the most compelling: despite the strong type 2 immune responses they induce, helminth infections can suppress allergy through regulatory pathways. Conversely, many helminths can cause allergic-type inflammation, including symptoms of "classical" allergic disease. From an evolutionary perspective, subjects with an effective immune response against helminths can be more susceptible to allergy. This narrative review aims to inform readers of the most relevant up-to-date evidence on the relationship between parasites and allergy. Experiments in animal models have demonstrated the potential benefits of helminth infection or administration of helminth-derived molecules on chronic inflammatory diseases, but thus far, clinical trials in human subjects have not demonstrated unequivocal clinical benefits. Nevertheless, there is sufficiently strong evidence to support continued investigation of the potential benefits of helminth-derived therapies for the prevention or treatment of allergic and other inflammatory diseases.
过敏性疾病在全球范围内呈上升趋势,而寄生虫感染则呈下降趋势。寄生虫感染与过敏在生态水平上呈负相关,提示两者之间存在因果关系。在人体研究中,已经产生了大量关于寄生虫感染和过敏之间复杂相互关系的知识基础。有因果关系的证据,但来自动物模型的数据最具说服力:尽管它们引起强烈的 2 型免疫反应,但寄生虫感染可以通过调节途径抑制过敏。相反,许多寄生虫会引起过敏性炎症,包括“经典”过敏性疾病的症状。从进化的角度来看,对寄生虫有有效免疫反应的宿主可能更容易患过敏。本综述旨在向读者介绍寄生虫与过敏之间关系的最新相关证据。动物模型实验已经证明了寄生虫感染或寄生虫来源的分子对慢性炎症性疾病的潜在益处,但到目前为止,人体临床试验并未显示出明确的临床益处。然而,有足够强的证据支持继续研究寄生虫衍生疗法在预防或治疗过敏和其他炎症性疾病方面的潜在益处。